Medicare coverage extended to Thermo's HeartMate:
This article was originally published in Clinica
The US Health Care Financing Administration has extended Medicare coverage to Thermo Cardiosystems' pneumatic HeartMate left ventricular assist system. The air-driven LVAS system is the only implantable heart device approved by the FDA for commercial sale, says Thermo.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.